Time course of ovarian tumour growth in soft agar culture.

por Verheijen, R. H., Feitz, W. F., Kenemans, P., Vooys, G. P., Herman, C. J.
Publicado 1985

CA 125 half-life in ovarian cancer: a multivariate survival analysis.

por Yedema, C. A., Kenemans, P., Voorhorst, F., Bon, G., Schijf, C., Beex, L., Verstraeten, A., Hilgers, J., Vermorken, J.
Publicado 1993

Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients.

por Gourevitch, M. M., von Mensdorff-Pouilly, S., Litvinov, S. V., Kenemans, P., van Kamp, G. J., Verstraeten, A. A., Hilgers, J.
Publicado 1995

Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma.

por Veenhuizen, R. B., Marijnissen, J. P., Kenemans, P., Ruevekamp-Helmers, M. C., 't Mannetje, L. W., Helmerhorst, T. J., Stewart, F. A.
Publicado 1996

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.

por Cromme, F. V., Meijer, C. J., Snijders, P. J., Uyterlinde, A., Kenemans, P., Helmerhorst, T., Stern, P. L., van den Brule, A. J., Walboomers, J. M.
Publicado 1993

Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.

por Cromme, F. V., van Bommel, P. F., Walboomers, J. M., Gallee, M. P., Stern, P. L., Kenemans, P., Helmerhorst, T. J., Stukart, M. J., Meijer, C. J.
Publicado 1994